A nurse reported via a sales representative that a (b)(6) female received solesta (dextranomer/hyaluronic acid) injection into the submucosa of the anal canal as treatment for fecal incontinence.Additional medical history included prior solesta injection in (b)(6) 2013 without problems.Concurrent medications were not provided.On (b)(6) 2014, the patient received solesta.On (b)(6) 2014, the patient was being evaluated in her physician's office for a burning sensation in her rectum and "not feeling well" which resulted in the patient having "trouble getting out of bed".Based on the subjective complaints, the physician suspected a possible abscess.The patient was sent for a computed tomography scan and blood work.She was diagnosed with a perirectal abscess and hospitalized.An incision and drainage was performed.On (b)(6) 2014, the patient was discharged with the drain still in place.As of (b)(6) 2014, the patient was recovering and the drain remained intact.Causality was not provided.The company assessed the events as possibly related to solesta.
|